DJ Regeneron Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 1.73% to $919.96 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 2.35% to 7,549.94 and the Dow Jones Industrial Average rising 2.15% to 52,389.75.
This was the stock's second consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 7.24% below its 52-week high of $991.73, which the company reached on November 4th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 1.04% to $465.23, Moderna Inc. (MRNA) rose 5.83% to $269.00, and Gilead Sciences Inc. (GILD) rose 1.46% to $169.32.
Trading volume (854,151) eclipsed its 50-day average volume of 802,140.
Data source: Dow Jones Market Data, FactSet. Data compiled November 9, 2026.
Comments